SCHEMBL25565896

SCHEMBL25565896

C#CCOC(=O)C(C)(COC(=O)C(C)(COC(=O)Oc1ccc([N+](=O)[O-])cc1)COC(=O)Oc1ccc([N+](=O)[O-])cc1)COC(=O)C(C)(COC(=O)Oc1ccc([N+](=O)[O-])cc1)COC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.46
BCL9 O00512 1/20 0.42
CTNNB1 P35222 1/20 0.42
GAA P10253 1/20 0.41
MGLL Q99685 2/20 0.41
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PTPN7 P35236 1/20 0.37
PTPN12 Q05209 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
SNCA P37840 1/20 0.37
MAPT P10636 5/20 0.37
POLB P06746 2/20 0.37
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27404548 0.99 HTR2A (0.46) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL19554277 0.85 HTR2A (0.54) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL2615578 0.84 HTR2A (0.47) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL25565815 0.84 HTR2A (0.47) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL2615571 0.82 HTR2A (0.48) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL26231112 0.80 HTR2A (0.57) HTR2ABCL9CTNNB1GAAALDH1A1
SCHEMBL2597473 0.79 HTR2A (0.56) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL18757845 0.76 HTR2A (0.54) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL21097318 0.76 HTR2A (0.54) HTR2ABCL9CTNNB1GAAMGLL
SCHEMBL21917194 0.76 BCL9 (0.47) HTR2ABCL9CTNNB1GAAMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207187-A1 DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY TIBA BIOTECH LLC (US) 2024-06-27 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207187-A1 DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY TLR3, TLR9, TLR6 HTR2A 4387/4885BCL9 1711/4885CTNNB1 4725/4885
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 HTR2A 4673/4885BCL9 592/4885CTNNB1 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.